PATENT CLAIM ANALYSIS

Application Number: 15880160
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "257000"]

Abstract:
The present invention provides a method of treating patients in need of treatment with long acting injectable paliperidone palmitate formulations.

Claim (Index 46):
The dosage regimen of  claim 45  wherein in the buffering agents contained in the aqueous nanoparticle suspension are citric acid monohydrate, disodium hydrogen phosphate anhydrous, sodium dihydrogen phosphate monohydrate, sodium hydroxide.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12337144', '15090889', '14555273', '14555287', '13500623']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614225906824825
- 35 USC 102 Novelty (BERT): 0.6569815664614108
- Combined Prediction Score: 0.7509784882603754
- Mean Citation Score: 425.511776
- Max Citation Score: 771.9951
- Similarity Product: 566.7691696750403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test